Related Experiment Video

Updated: Aug 11, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Genetic variation in the myeloperoxidase gene and cognitive impairment in multiple sclerosis

I Manna1, P Valentino, A La Russa

  • 1Institute of Neurological Science, National Research Council, Cosenza, Italy. i.manna@isn.cnr.it

Journal of Negative Results in Biomedicine
|March 1, 2006
PubMed

Insights

This study found that a specific myeloperoxidase (MPO) gene polymorphism is not associated with cognitive impairment in multiple sclerosis (MS) patients. The MPO gene

Area of Science:

  • Neuroimmunology
  • Genetics
  • Cognitive Neurology

Background:

  • Multiple sclerosis (MS) is frequently associated with cognitive impairment, affecting 25-40% of patients.
  • The myeloperoxidase (MPO) gene is implicated in pathways relevant to beta-amyloid deposition, a factor in cognitive decline.

Purpose of the Study:

  • To investigate the association between a functional MPO gene polymorphism (-463 G/A) and cognitive impairment in multiple sclerosis patients.

Main Methods:

  • Genotyping of the MPO -463 G/A polymorphism in 465 MS patients.
  • Categorization of patients into cognitively normal (n=204) and impaired (n=261) groups.
  • Statistical analysis of allele and genotype distributions between groups.

Main Results:

  • No significant differences were observed in MPO -463 G/A allele frequencies between cognitively impaired and normal MS patients.
  • Genotype distributions for the MPO polymorphism did not differ significantly between the two cognitive groups.
  • These findings indicate no correlation between this MPO variant and cognitive status in the studied MS cohort.

Conclusions:

  • The investigated MPO gene polymorphism (-463 G/A) does not appear to be a genetic risk factor for cognitive impairment in multiple sclerosis.
  • Further research may explore other genetic or environmental factors contributing to MS-related cognitive dysfunction.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...